Journal article
Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non‐rhabdomyosarcoma soft tissue sarcomas
Abstract
BACKGROUND: Soft tissue sarcomas (STS) are a highly heterogeneous group of rare malignant solid tumors. Non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) comprise all STS except rhabdomyosarcoma. In patients with advanced local or metastatic disease, autologous hematopoietic stem cell transplantation (HSCT) applied after high-dose chemotherapy (HDCT) is a planned rescue therapy for HDCT-related severe hematologic toxicity. The rationale for …
Authors
Peinemann F; Smith LA; Bartel C
Journal
, Vol. 2013, No. 8,
Publisher
Wiley
DOI
10.1002/14651858.cd008216.pub4
ISSN
1465-1858